• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport.

作者信息

Augustijns P F, Bradshaw T P, Gan L S, Hendren R W, Thakker D R

机构信息

Drug Metabolism Department, Glaxo Inc. Research Institute, Research Triangle Park, North Carolina 27709.

出版信息

Biochem Biophys Res Commun. 1993 Dec 15;197(2):360-5. doi: 10.1006/bbrc.1993.2487.

DOI:10.1006/bbrc.1993.2487
PMID:7903526
Abstract

The characteristics of cyclosporin A (CsA) transport across Caco-2 monolayers were investigated. CsA (0.25-5.0 microM) was transported in a time and concentration dependent manner. The total amount of apical (AP) to basolateral (BL) transport was non-linearly related to CsA concentration from 0.25 to 1 microM and was linear from about 1 to 5 microM. Average permeability coefficient (Papp) values obtained in the AP to BL direction showed CsA concentration (0.5 and 5.0 microM) dependence, whereas those of the reverse (BL to AP) process did not. Papp values for the AP to BL direction were also markedly lower. When the P-glycoprotein pump inhibitors, chlorpromazine and progesterone, were included in the transport medium we observed a significant increase in CsA (0.5 and 5.0 microM) transport from the AP to BL direction; transport was decreased in the reverse direction. This study suggests that CsA is transported across Caco-2 cells by passive diffusion, but that a polarized efflux system (presumably a P-glycoprotein pump) located at the apical membrane can attenuate the net AP to BL transport.

摘要

相似文献

1
Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport.
Biochem Biophys Res Commun. 1993 Dec 15;197(2):360-5. doi: 10.1006/bbrc.1993.2487.
2
CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells.CYP3A样细胞色素P450介导的环孢素A在Caco-2细胞中的代谢及极化流出
Drug Metab Dispos. 1996 Mar;24(3):344-9.
3
Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.负责限制阿片肽DADLE的香豆酸基环前药在肠道黏膜渗透的外排转运体的表征。
Pharm Res. 2002 Jun;19(6):787-93. doi: 10.1023/a:1016196514217.
4
Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter.阿托伐他汀在Caco-2细胞模型中的转运:P-糖蛋白和质子-单羧酸共转运体的作用
Pharm Res. 2000 Feb;17(2):209-15. doi: 10.1023/a:1007525616017.
5
Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance protein efflux transporter.表达高水平多药耐药蛋白外排转运体的Caco-2亚克隆的分离与鉴定
Pharm Res. 2003 Feb;20(2):161-8. doi: 10.1023/a:1022359300826.
6
Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers.P-糖蛋白gp170在Caco-2细胞单层中的年龄依赖性表达。
Pharm Res. 1996 Jun;13(6):885-90. doi: 10.1023/a:1016005212640.
7
Carrier mechanisms involved in the transepithelial transport of bis(POM)-PMEA and its metabolites across Caco-2 monolayers.参与双(POM)-PMEA及其代谢产物跨Caco-2单层细胞进行跨上皮转运的载体机制。
Pharm Res. 1998 Aug;15(8):1168-73. doi: 10.1023/a:1011923420719.
8
Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of an acyloxyalkoxy-based cyclic prodrug of the opioid peptide DADLE.负责限制阿片肽DADLE的基于酰氧基烷氧基的环状前药的肠道黏膜渗透的外排转运体的表征。
Pharm Res. 2002 Jun;19(6):780-6. doi: 10.1023/a:1016144530146.
9
Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.维拉帕米、环孢素A和SDZ PSC 833对P-糖蛋白介导的长春碱跨HCT-8肠癌细胞单层转运的抑制作用与细胞外pH的关系
Cancer Chemother Pharmacol. 1994;34(2):125-32. doi: 10.1007/BF00685929.
10
Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein.多药转运蛋白P-糖蛋白限制环孢素A穿过血脑屏障。
Biochem Pharmacol. 1993 Sep 14;46(6):1096-9. doi: 10.1016/0006-2952(93)90677-o.

引用本文的文献

1
Molecular Modelling in Bioactive Peptide Discovery and Characterisation.生物活性肽发现与表征中的分子建模
Biomolecules. 2025 Apr 3;15(4):524. doi: 10.3390/biom15040524.
2
The backbone constitution drives passive permeability independent of side chains in depsipeptide and peptide macrocycles inspired by -verticilide.受轮枝菌素启发的缩肽和肽大环化合物中,主链结构驱动被动渗透性,与侧链无关。
Chem Sci. 2024 Aug 15;15(36):14977-87. doi: 10.1039/d4sc02758b.
3
Challenges in Permeability Assessment for Oral Drug Product Development.口服药物产品开发中渗透性评估的挑战。
Pharmaceutics. 2023 Sep 28;15(10):2397. doi: 10.3390/pharmaceutics15102397.
4
Label-free quantification of passive membrane permeability of cyclic peptides across lipid bilayers: penetration speed of cyclosporin A across lipid bilayers.环肽跨脂质双层被动膜通透性的无标记定量:环孢素A跨脂质双层的渗透速度。
Chem Sci. 2022 Dec 6;14(2):345-349. doi: 10.1039/d2sc05785a. eCollection 2023 Jan 4.
5
Intestinal absorption of BCS class II drugs administered as nanoparticles: A review based on data from intestinal perfusion models.作为纳米颗粒给药的BCS II类药物的肠道吸收:基于肠道灌注模型数据的综述
ADMET DMPK. 2020 Sep 17;8(4):375-390. doi: 10.5599/admet.881. eCollection 2020.
6
Nanostructured Valsartan Microparticles with Enhanced Bioavailability Produced by High-Throughput Electrohydrodynamic Room-Temperature Atomization.高通量室温电喷射制备具有增强生物利用度的纳米结构缬沙坦微球。
Mol Pharm. 2021 Aug 2;18(8):2947-2958. doi: 10.1021/acs.molpharmaceut.1c00098. Epub 2021 Jun 28.
7
Getting across the cell membrane: an overview for small molecules, peptides, and proteins.穿越细胞膜:小分子、肽和蛋白质概述
Methods Mol Biol. 2015;1266:29-53. doi: 10.1007/978-1-4939-2272-7_3.
8
Loss of orally administered drugs in GI tract.胃肠道中口服药物的损失。
Saudi Pharm J. 2012 Oct;20(4):331-44. doi: 10.1016/j.jsps.2012.03.005. Epub 2012 Apr 20.
9
Approaches for enhancing oral bioavailability of peptides and proteins.提高肽和蛋白质口服生物利用度的方法。
Int J Pharm. 2013 Apr 15;447(1-2):75-93. doi: 10.1016/j.ijpharm.2013.02.030. Epub 2013 Feb 18.
10
Cyclodextrins in drug delivery: an updated review.环糊精在药物递送中的应用:最新综述
AAPS PharmSciTech. 2005 Oct 14;6(2):E329-57. doi: 10.1208/pt060243.